Steven Cohen's EDIT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 125,234 shares of Editas Medicine, Inc. (EDIT) worth $405,758, representing 0.00% of the portfolio. First purchased in 2018-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in EDIT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 733,483 shares. Largest reduction occurred in Q1 2026, reducing 616,488 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Editas Medicine (EDIT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Editas Medicine (EDIT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +8,239 | Add 7.04% | 125,234 | $3.24 |
| Q1 2026 | -616,488 | Reduce 84.05% | 116,995 | $2.47 |
| Q4 2025 | +733,483 | New Buy | 733,483 | $2.05 |
| Q4 2024 | -107,360 | Sold Out | 0 | $0.00 |
| Q3 2024 | +107,360 | New Buy | 107,360 | $3.41 |
| Q1 2024 | -579,967 | Sold Out | 0 | $0.00 |
| Q4 2023 | +577,767 | Add 26262.14% | 579,967 | $10.13 |
| Q3 2023 | -879 | Reduce 28.55% | 2,200 | $7.80 |
| Q2 2023 | -224,721 | Reduce 98.65% | 3,079 | $8.23 |
| Q1 2023 | +227,800 | New Buy | 227,800 | $7.25 |
| Q1 2019 | -58,745 | Sold Out | 0 | $0.00 |
| Q4 2018 | -38,655 | Reduce 39.69% | 58,745 | $22.74 |
| Q3 2018 | +97,400 | New Buy | 97,400 | $31.82 |
Steven Cohen's Editas Medicine Investment FAQs
Steven Cohen first purchased Editas Medicine, Inc. (EDIT) in Q3 2018, acquiring 97,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Editas Medicine, Inc. (EDIT) for 13 quarters since Q3 2018.
Steven Cohen's largest addition to Editas Medicine, Inc. (EDIT) was in Q4 2025, adding 733,483 shares worth $1.5 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 125,234 shares of Editas Medicine, Inc. (EDIT), valued at approximately $405,758.
As of the Q2 2026 filing, Editas Medicine, Inc. (EDIT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Editas Medicine, Inc. (EDIT) was 733,483 shares, as reported at the end of Q4 2025.